Onsdag 5 Februari | 18:59:27 Europe / Stockholm

Kalender

Tid*
2025-08-29 N/A Kvartalsrapport 2025-Q2
2025-05-15 N/A Årsstämma
2025-03-28 N/A Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning CANATU 0.00 EUR
2024-06-19 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-09 - X-dag ordinarie utdelning CANATU 0.00 EUR
2023-03-02 - Bokslutskommuniké 2022
2022-09-15 - Kvartalsrapport 2022-Q2
2022-05-18 - Årsstämma
2022-05-17 - X-dag ordinarie utdelning CANATU 0.00 EUR

Beskrivning

LandFinland
ListaFirst North Finland
SektorFinans
IndustriInvesteringar
Canatu är ett teknikbolag verksamt inom djupteknologi som skapar kolnanorör (Canatu CNT), relaterade produkter och tillverkningsutrustning för halvledar-, fordons- och medicinsk diagnostikindustri. Bolaget verkar genom två affärsmodeller, för det första genom sina egna reaktorer för att utveckla och tillverka CNT-produkter. För det andra säljer bolaget sina CNT-reaktorer och licensierar dess relaterade teknologi, för att kunder ska kunna producera produkterna själva under en begränsad licens.
2024-12-11 15:30:00

Canatu Plc Company release 11 December 2024 at 4:30 pm EET

Composition of Canatu Plc's Shareholders' Nomination Board

The members of Canatu Plc’s (“Canatu”) Shareholders’ Nomination Board have been appointed. The composition of the Shareholders’ Nomination Board as of 11 December 2024 is the following:

  • Ari Ahola, Chairman of the Board of Directors, eFruit International, Inc. (appointed by eFruit International, Inc.)
  • Anthony Cannestra, Director of Corporate Ventures, DENSO International America (appointed by DENSO Corporation)
  • Denis Cherkasov, Director, Mymetics Holdings (appointed by Mymetics Holding (Cyprus) Limited)
  • Timo Sallinen, Director, Head of Listed Securities, Varma Mutual Pension Insurance Company (appointed by Varma Mutual Pension Insurance Company)

The Nomination Board elected Ari Ahola as Chair from among its members. In accordance with the Charter of the Shareholders’ Nomination Board, the Shareholders’ Nomination Board consists of four members, representing Canatu’s four largest shareholders, who held the largest number of votes in Canatu based on the shareholders’ register as per the situation on the first banking day of October 2024, considering the nominee-registered shares, and exercised their right of appointment. As the fourth largest shareholder Inventure Fund Ky did not exercise its right of appointment, the right was transferred to the fifth largest shareholder in accordance with the Charter of the Shareholders’ Nomination Board, i.e., Varma Mutual Pension Insurance Company, which appointed the fourth member of the Shareholder’s Nomination Board.

The Chair of Canatu’s Board of Directors participates in the Shareholders’ Nomination Board’s work as an expert without having a right to participate in the decision-making of the Shareholders’ Nomination Board.

The Shareholders’ Nomination Board is a corporate body appointed by Canatu’s shareholders that is responsible for preparing proposals to the annual general meeting, and if necessary, to the extraordinary general meeting, on the number, election, and remuneration of the members of the Board of Directors. More information on the Shareholders’ Nomination Board is available on Canatu’s website at: https://canatu.com/investors/governance/shareholders-nomination-board/.

Additional information

Timo Ahopelto

Chair of the Board of Directors

tel. +358 400 569 628

Certified adviser

Carnegie Investment Bank AB (publ)
tel. +46 (0)73 856 42 65

About Canatu 

Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.  

Canatu's versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.  

Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 130 employees representing over 30 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn